This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
The Joint Corp. (JYNT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
The Joint Corp. (JYNT) closed the most recent trading day at $17.50, moving +0.34% from the previous trading session.
The Joint Corp. (JYNT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
The Joint Corp. (JYNT) closed the most recent trading day at $15.94, moving -1.48% from the previous trading session.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MGLN vs MOH: Which Health Insurance Stock is Placed Better?
by Zacks Equity Research
Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.
4 Stocks to Buy Despite Year-to-Date Fall in Health Insurance
by Sapna Bagaria
Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Why You Should Hold Tenet Healthcare (THC) in Your Portfolio
by Zacks Equity Research
Banking on a strong inorganic growth history and strategic divestitures, Tenet Healthcare (THC) holds immense potential to reap benefits for investors.
Why Should You Hold Centene (CNC) in Your Portfolio Now?
by Zacks Equity Research
Banking on a robust revenues and strategic initiatives, Centene (CNC) has immense potential to reap benefits for investors.
Why Should You Hold Anthem (ANTM) in Your Portfolio Now?
by Zacks Equity Research
Riding high on a solid revenue stream and a sturdy capital position, Anthem (ANTM) holds strong prospects to garner benefits for investors.
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: The Joint Corp (JYNT)
by Brian Bolan
This stock has a smoking chart, but it's not that type of "joint"
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
Why You Should Hold Humana (HUM) Stock in Your Portfolio
by Zacks Equity Research
Humana (HUM) rides high on solid Medicare business growth and its strategic efforts. The stock holds immense potential to reap solid benefits for investors.
5 Top US-Focused Stocks to Buy as Trade Negotiations Stall
by Nalak Das
Trade-sensitive stocks, especially the ones that have large exposure to China or other international markets, lost a good chunk of value.
The Joint Corp. (JYNT) Is Up 9.28% in One Week: What You Should Know
by Zacks Equity Research
Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
The Joint Corp. (JYNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?